Osteogenic Growth Peptide (10-14) acetate NEW
| Price | $227 | $397 | $572 |
| Package | 1mg | 2mg | 5mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-10-26 |
Product Details
| Product Name: Osteogenic Growth Peptide (10-14) acetate | Purity: 98.69% |
| Supply Ability: 10g | Release date: 2025/10/26 |
Product Introduction
Bioactivity
| Name | Osteogenic Growth Peptide (10-14) acetate |
| Description | Osteogenic Growth Peptide (10-14) acetate (Osteogenic Growth Peptide) is a Src inhibitor and an effective mitogen and stimulator of osteogenesis and hematopoiesis. Osteogenic Growth Peptide (10-14) acetate is responsible for the binding to the OGP receptor and activates an intracell |
| In vitro | In fibroblast and osteoblast cell lines, Osteogenic Growth Peptide (10-14) acetate induced proliferation and differentiation[2]. Osteogenic Growth Peptide (10-14) acetate induced TPO-primed M07-e cells differentiation through RhoA/TGFβ1/SFKs signalling pathway[3]. |
| In vivo | In mice and rats, Osteogenic Growth Peptide (10-14) acetate increased bone formation and trabecular bone density and stimulated fracture healing[4]. |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 5.6 mg/mL (10.01 mM), Sonication is recommended. |
| Keywords | Src | Osteogenic Growth Peptide (1014) acetate | Osteogenic Growth Peptide (10 14) acetate | Osteogenic Growth Peptide Acetate | Osteogenic Growth Peptide |
| Inhibitors Related | Nintedanib | Vemurafenib | SI-2 hydrochloride | Staurosporine | Bosutinib hydrate | Ibrutinib | Dasatinib | Ponatinib | Pelitinib | Tofacitinib | TAK-901 | Masitinib |
| Related Compound Libraries | Bioactive Compound Library | Membrane Protein-targeted Compound Library | HIF-1 Signaling Pathway Compound Library | Kinase Inhibitor Library | Tyrosine Kinase Inhibitor Library | Peptide Compound Library | Angiogenesis related Compound Library | Inhibitor Library | Mitochondria-Targeted Compound Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $297.00/2mg |
VIP4Y
|
TargetMol Chemicals Inc.
|
2025-08-21 | |
| $0.00/25kg |
VIP4Y
|
Shanghai Joiny Pharmaceutical Co.,LTD
|
2025-09-22 | |
| $0.00/1kg |
VIP1Y
|
Hebei Junhua Import and Export Co., LTD
|
2025-03-05 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY